Phathom Pharmaceuticals, Inc. — Director's Dealing 2024

Jan 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2024-01-18

Reporting Person: Nabulsi Azmi (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-18	Stock Option (Right to Buy)	$7.60	A	130000	Acquired	2034-01-17	Common Stock (130000)	Direct

Footnotes

F1: The stock option will vest with respect to 25% of the shares of common stock on January 18, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.